Skip to main content

Susan Kay Murphy, PhD

Property title
Associate Professor in Obstetrics and Gynecology
Campus Mail: 226 B Wing LSRC, 450 Research Drive, Durham, NC 27708
Phone: (919) 681-3423
Email: susan.murphy@duke.edu

Ovarian and cervical cancer epigenetics, imprinted genes in ovarian and cervical cancers, identification of methylation biomarkers of disease, ovarian cancer stem cells, chemotherapeutic response in ovarian cancer, tumor dormancy, the influence of the in utero environment on DNA methylation and risk of disease.

Education and Training

  • Ph.D., Wake Forest University, 1998
  • B.A., University of North Carolina at Charlotte, 1992

Selected Grants and Awards

Publications

Hoyo, C, Murtha, AP, Schildkraut, JM, Forman, MR, Calingaert, B, Demark-Wahnefried, W, Kurtzberg, J, Jirtle, RL, and Murphy, SK. "Folic acid supplementation before and during pregnancy in the Newborn Epigenetics STudy (NEST). (Published online)" BMC Public Health 11, no. 1 (January 21, 2011): 46-.

Full Text

Matsumura, N, Huang, Z, Mori, S, Baba, T, Fujii, S, Konishi, I, Iversen, ES, Berchuck, A, and Murphy, SK. "Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancer." Genome Res 21, no. 1 (January 2011): 74-82.

Full Text

Bernal, AJ, Murphy, SK, and Jirtle, RL. "Mouse models of epigenetic inheritance." Handbook of Epigenetics (2011): 233-249.

Full Text

Matsumura, N, Mandai, M, Okamoto, T, Yamaguchi, K, Yamamura, S, Oura, T, Baba, T, Hamanishi, J, Kang, HS, Matsui, S, Mori, S, Murphy, SK, and Konishi, I. "Sorafenib efficacy in ovarian clear cell carcinoma revealed by transcriptome profiling." Cancer Sci 101, no. 12 (December 2010): 2658-2663.

Full Text

Bernardini, MQ, Baba, T, Lee, PS, Barnett, JC, Sfakianos, GP, Secord, AA, Murphy, SK, Iversen, E, Marks, JR, and Berchuck, A. "Expression signatures of TP53 mutations in serous ovarian cancers. (Published online)" BMC Cancer 10 (May 26, 2010): 237-.

Full Text

Kondoh, E, Mori, S, Yamaguchi, K, Baba, T, Matsumura, N, Cory Barnett, J, Whitaker, RS, Konishi, I, Fujii, S, Berchuck, A, and Murphy, SK. "Targeting slow-proliferating ovarian cancer cells." Int J Cancer 126, no. 10 (May 15, 2010): 2448-2456.

Full Text

Yamaguchi, K, Mandai, M, Oura, T, Matsumura, N, Hamanishi, J, Baba, T, Matsui, S, Murphy, SK, and Konishi, I. "Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes." Oncogene 29, no. 12 (March 25, 2010): 1741-1752.

Full Text

Lee, PS, Teaberry, VS, Bland, AE, Huang, Z, Whitaker, RS, Baba, T, Fujii, S, Secord, AA, Berchuck, A, and Murphy, SK. "Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer." Int J Cancer 126, no. 6 (March 15, 2010): 1378-1389.

Full Text

Barnett, JC, Bean, SM, Whitaker, RS, Kondoh, E, Baba, T, Fujii, S, Marks, JR, Dressman, HK, Murphy, SK, and Berchuck, A. "Ovarian cancer tumor infiltrating T-regulatory (T(reg)) cells are associated with a metastatic phenotype." Gynecol Oncol 116, no. 3 (March 2010): 556-562.

Full Text

Murphy, SK. "Targeting ovarian cancer-initiating cells." Anticancer Agents Med Chem 10, no. 2 (February 2010): 157-163. (Review)

Scholars@Duke

Pages